Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
Tóm tắt
Từ khóa
Tài liệu tham khảo
Zuberbier, 2009, EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria, Allergy, 64, 1417, 10.1111/j.1398-9995.2009.02179.x
Magerl, 2009, The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations, Allergy, 64, 1715, 10.1111/j.1398-9995.2009.02177.x
Swinny, 1941, The atopic factor in urticaria, South Med J, 34, 855, 10.1097/00007611-194108000-00014
Sheldon, 1954, The vexing urticaria problem: present concepts of etiology and management, J Allergy, 25, 525, 10.1016/S0021-8707(54)90034-9
Gaig, 2004, Epidemiology of urticaria in Spain, J Investig Allergol Clin Immunol, 14, 214
Bakke, 1990, Hay fever, eczema and urticaria in southwest Norway Lifetime prevalences and association with sex, age, smoking habits, occupational airborne exposures and respiratory symptoms, Allergy, 45, 515, 10.1111/j.1398-9995.1990.tb00527.x
Herrmann-Kunz, 1999, Häufigkeit allergischer Krankheiten in Ost- und Westdeutschland, Gesundheitswesen, 61, 100
Zuberbier, 2010, Epidemiology of urticaria: a representative cross-sectional population survey, Clin Exp Dermatol, 10.1111/j.1365-2230.2010.03840.x
Hellgren, 1972, The prevalence of urticaria in the total population, Acta Allergol, 27, 236, 10.1111/j.1398-9995.1972.tb01420.x
van der Valk, 2002, The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre, Br J Dermatol, 146, 110, 10.1046/j.1365-2133.2002.04582.x
Kozel, 2001, Natural course of physical and chronic urticaria and angioedema in 220 patients, J Am Acad Dermatol, 45, 387, 10.1067/mjd.2001.116217
Kulthanan, 2007, Chronic idiopathic urticaria: prevalence and clinical course, J Dermatol, 34, 294, 10.1111/j.1346-8138.2007.00276.x
Humphreys, 1998, The characteristics of urticaria in 390 patients, Br J Dermatol, 138, 635, 10.1046/j.1365-2133.1998.02175.x
Sibbald, 1991, Chronic urticaria. Evaluation of the role of physical, immunologic, and other contributory factors, Int J Dermatol, 30, 381, 10.1111/j.1365-4362.1991.tb03891.x
Small, 1982, Chronic urticaria and angioedema, Clin Allergy, 12, 131, 10.1111/j.1365-2222.1982.tb01631.x
Quaranta, 1989, The natural history and response to therapy of chronic urticaria and angioedema, Ann Allergy, 62, 421
Juhlin, 1981, Recurrent urticaria: clinical investigation of 330 patients, Br J Dermatol, 104, 369, 10.1111/j.1365-2133.1981.tb15306.x
Toubi, 2004, Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients, Allergy, 59, 869, 10.1111/j.1398-9995.2004.00473.x
Champion, 1969, Urticaria and angio-oedema. A review of 554 patients, Br J Dermatol, 81, 588, 10.1111/j.1365-2133.1969.tb16041.x
Steinhardt, 1954, Urticaria and angioedema - statistical survey of five hundred cases, Ann Allergy, 12, 659
Sabroe, 1999, Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies, J Am Acad Dermatol, 40, 443, 10.1016/S0190-9622(99)70495-0
Nettis, 2002, Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria, Clin Exp Dermatol, 27, 29, 10.1046/j.0307-6938.2001.00962.x
Caproni, 2004, Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects, Acta Derm Venereol, 84, 288, 10.1080/00015550410026939
Giménez Arnau, 2004, Urticaria crónica: studio etiológico prospectivo e importancia del síndrome autoinmune, Actas Dermosifiliogr, 95, 560, 10.1016/S0001-7310(04)76883-0
Ferrer, 2009, Epidemiology, healthcare, resources, use and clinical features of different types of urticaria, J Investig Allergol Clin Immunol, 2, 21
Młynek, 2009, The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings, Allergy, 64, 927, 10.1111/j.1398-9995.2008.01920.x
Tanaka, 2006, Analysis of the prevalence of subtypes of urticaria and angioedema, Arerugi, 55, 134
Metz, 2009, Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria, J Allergy Clin Immunol, 123, 705, 10.1016/j.jaci.2008.11.040
Konstantinou, 2009, EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria, Allergy, 64, 1256, 10.1111/j.1398-9995.2009.02132.x
Staubach, 2006, Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial, Dermatology, 212, 150, 10.1159/000090656
Arck, 2006, Neuroimmunology of stress: skin takes center stage, J Invest Dermatol, 126, 1697, 10.1038/sj.jid.5700104
Al’Abadie, 1994, The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions, Br J Dermatol, 130, 199, 10.1111/j.1365-2133.1994.tb02900.x
Chung, 2010, The relationship between posttraumatic stress disorder, psychiatric comorbidity, and personality traits among patients with chronic idiopathic urticaria, Compr Psychiatry, 51, 55, 10.1016/j.comppsych.2009.02.005
Chung, 2010, Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria, Psychol Health, 25, 477, 10.1080/08870440802530780
Fava, 1980, Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections, Br J Med Psychol, 53, 277, 10.1111/j.2044-8341.1980.tb02551.x
Malhotra, 2008, Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria, Indian J Dermatol Venereol Leprol, 74, 594, 10.4103/0378-6323.45100
Yang, 2005, Stress, insomnia, and chronic idiopathic urticaria - a case-control study, J Formos Med Assoc, 104, 254
Shertzer, 1987, Effects of relaxation therapy and hypnotizability in chronic urticaria, Arch Dermatol, 123, 913, 10.1001/archderm.123.7.913
Daniels, 1973, Treatment of urticaria and severe headache by behavior therapy. A case study, Psychosomatics, 14, 347, 10.1016/S0033-3182(73)71307-4
Baiardini, 2010, Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper, Allergy, 65, 290, 10.1111/j.1398-9995.2009.02263.x
Zuberbier, 2009, EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria, Allergy, 64, 1427, 10.1111/j.1398-9995.2009.02178.x
O’Donnell, 1997, The impact of chronic urticaria on the quality of life, Br J Dermatol, 136, 197, 10.1111/j.1365-2133.1997.tb14895.x
Baiardini, 2003, Quality of life and patients’ satisfaction in chronic urticaria and respiratory allergy, Allergy, 58, 621, 10.1034/j.1398-9995.2003.00091.x
Grob, 2005, Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life, Br J Dermatol, 152, 289, 10.1111/j.1365-2133.2005.06385.x
Staubach, 2006, Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity, Br J Dermatol, 154, 294, 10.1111/j.1365-2133.2005.06976.x
Maurer, 2009, Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation, Allergy, 64, 581, 10.1111/j.1398-9995.2008.01853.x
Lewis, 2004, 10 years experience of the Dermatology Life Quality Index (DLQI), J Investig Dermatol Symp Proc, 9, 169, 10.1111/j.1087-0024.2004.09113.x
Baiardini, 2005, A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL), Allergy, 60, 1073, 10.1111/j.1398-9995.2005.00833.x
Yosipovitch, 2002, Clinical characteristics of pruritus in chronic idiopathic urticaria, Br J Dermatol, 147, 32, 10.1046/j.1365-2133.2002.04758.x
Maurer, 2009, Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients, Br J Dermatol, 160, 633, 10.1111/j.1365-2133.2008.08920.x
Roth, 2003, Insomnia: epidemiology, characteristics, and consequences, Clin Cornerstone, 5, 5, 10.1016/S1098-3597(03)90031-7
Gupta, 1994, Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria, Psychosom Med, 56, 36, 10.1097/00006842-199401000-00005
Picardi, 2000, Psychiatric morbidity in dermatological outpatients: an issue to be recognized, Br J Dermatol, 143, 983, 10.1046/j.1365-2133.2000.03831.x
Uguz, 2008, Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria, J Psychosom Res, 64, 225, 10.1016/j.jpsychores.2007.08.006
Engin, 2008, The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria, J Eur Acad Dermatol Venereol, 22, 36, 10.1111/j.1468-3083.2007.02324.x
Uguz, 2008, Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders, Gen Hosp Psychiatry, 30, 453, 10.1016/j.genhosppsych.2008.06.006
Delong, 2008, Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients, Arch Dermatol, 144, 35, 10.1001/archdermatol.2007.5
Kapp, 2006, Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials, Clin Drug Investig, 26, 1, 10.2165/00044011-200626010-00001
Champion, 1988, Urticaria: then and now, Br J Dermatol, 119, 427, 10.1111/j.1365-2133.1988.tb03246.x
Church, 2010, Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper, Allergy, 65, 459, 10.1111/j.1398-9995.2009.02325.x
Staevska, 2010, The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria, J Allergy Clin Immunol, 125, 676, 10.1016/j.jaci.2009.11.047
Dubertret, 2007, Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study, Eur J Dermatol, 17, 223
Siebenhaar, 2009, High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study, J Allergy Clin Immunol, 123, 672, 10.1016/j.jaci.2008.12.008
Kameyoshi, 2007, Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients, Br J Dermatol, 157, 803, 10.1111/j.1365-2133.2007.08060.x
Grattan, 2000, Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria, Br J Dermatol, 143, 365, 10.1046/j.1365-2133.2000.03664.x
Vena, 2006, Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial, J Am Acad Dermatol, 55, 705, 10.1016/j.jaad.2006.04.078
Metz, 2010, Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria, Int Arch Allergy Immunol, 154, 177, 10.1159/000320233
Magerl, 2010, Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab, J Allergy Clin Immunol, 126, 665, 10.1016/j.jaci.2010.05.047
Kaplan, 2008, Treatment of chronic autoimmune urticaria with omalizumab, J Allergy Clin Immunol, 122, 569, 10.1016/j.jaci.2008.07.006
Spector, 2008, Therapeutic alternatives for chronic urticaria: additional reports on omalizumab, Ann Allergy Asthma Immunol, 101, 647, 10.1016/S1081-1206(10)60232-3
Spector, 2007, Effect of omalizumab on patients with chronic urticaria, Ann Allergy Asthma Immunol, 99, 190, 10.1016/S1081-1206(10)60644-8
Zhang, 2009, Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial, J Int Med Res, 37, 1167, 10.1177/147323000903700422
Giménez-Arnau, 2009, The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg, J Eur Acad Dermatol Venereol, 23, 1088, 10.1111/j.1468-3083.2009.03289.x
Potter, 2009, Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients, Allergy, 64, 596, 10.1111/j.1398-9995.2008.01893.x
Engin, 2008, Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial, Acta Derm Venereol, 88, 247, 10.2340/00015555-0434
Grob, 2008, Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study, J Eur Acad Dermatol Venereol, 22, 87, 10.1111/j.1468-3083.2007.02385.x
Khalaf, 2008, Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria, J Eur Acad Dermatol Venereol, 22, 487, 10.1111/j.1468-3083.2007.02511.x
Gimenez-Arnau, 2007, Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study, Allergy, 62, 539, 10.1111/j.1398-9995.2007.01330.x
Spector, 2007, The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria, Cutis, 79, 157
Ortonne, 2007, Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial, Am J Clin Dermatol, 8, 37, 10.2165/00128071-200708010-00005
Pons-Guiraud, 2006, Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial, Eur J Dermatol, 16, 649
Godse, 2006, Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine, Indian J Dermatol Venereol Leprol, 72, 312, 10.4103/0378-6323.26735
Kapp, 2006, Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study, Int J Dermatol, 45, 469, 10.1111/j.1365-4632.2005.02609.x
Nettis, 2006, Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study, Br J Dermatol, 154, 533, 10.1111/j.1365-2133.2005.07049.x
Kaplan, 2005, Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study, Ann Allergy Asthma Immunol, 94, 662, 10.1016/S1081-1206(10)61325-7
Di Lorenzo, 2004, Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria, J Allergy Clin Immunol, 114, 619, 10.1016/j.jaci.2004.06.018
Nettis, 2004, Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study, Clin Exp Allergy, 34, 1401, 10.1111/j.1365-2222.2004.02019.x
Handa, 2004, Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria, J Dermatolog Treat, 15, 55, 10.1080/09546630310013450
Monroe, 2003, Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial, J Am Acad Dermatol, 48, 535, 10.1067/mjd.2003.143
La Rosa, 2001, Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children, Ann Allergy Asthma Immunol, 87, 48, 10.1016/S1081-1206(10)62322-8
Camarasa, 2001, Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial, Skin Pharmacol Appl Skin Physiol, 14, 77, 10.1159/000056337
Ring, 2001, Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study, Int J Dermatol, 40, 72, 10.1046/j.1365-4362.2001.00186.x
Nelson, 2000, Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria, Ann Allergy Asthma Immunol, 84, 517, 10.1016/S1081-1206(10)62515-X
Leynadier, 2000, Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group, Eur J Dermatol, 10, 205
Finn, 1999, A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria, J Allergy Clin Immunol, 104, 1071, 10.1016/S0091-6749(99)70091-6
Dubertret, 1999, Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study, J Eur Acad Dermatol Venereol, 12, 16, 10.1111/j.1468-3083.1999.tb00802.x
Breneman, 1996, Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria, Ann Pharmacother, 30, 1075, 10.1177/106002809603001001
Brostoff, 1996, Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria, Allergy, 51, 320, 10.1111/j.1398-9995.1996.tb00092.x
Breneman, 1995, Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial, J Am Acad Dermatol, 33, 192, 10.1016/0190-9622(95)90233-3